Precision-guided, self-assembling vaccines for cancer and infectious diseases

Voltron Therapeutics, Inc. is improving cell mediated responses to combat infectious diseases, such as COVID-19 and specific forms of cancers, using the advanced and proprietary VaxCelerate™ Self-Assembling Vaccine Design developed by specialists at the Massachusetts General Hospital (MGH) and the Vaccine & Immunotherapy Center. Voltron has an exclusive license to this technology from MGH.

Watch the video below to learn more